Organization Profile

You just read:

EUSA Pharma Acquires Development and Commercialization Rights to ASPAREC® for Treatment of Acute Lymphoblastic Leukemia from Alizé Pharma

News provided by

EUSA Pharma Inc.

Feb 02, 2012, 04:30 ET